Jan 2019 Corporation Presentation, Slide 20.
BETonMACE Clinical Trial Analysis Points and Time Lines
.
.
5. Top line data will be announced after adjudication completion. Key subgroup analyses will also be released if available – Renal & Cognitive function.
6. H2 2019 and beyond – full outcomes, pre-specified endpoint data, safety results, and clinical implications will be reported and published.